Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer
Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds
Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation
Smoking Increases Breast Cancer Risk Based on Genes
Larynx Preservation Provides Better Voice Quality For Patients
PET Better At Evaluating Response In Sarcoma
Sorafenib Targets AML Driven By Mutant FLT3 Gene
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”